Latest Regulatory News

Arika Resources has launched an expanded 10,000m drilling campaign at its Yundamindra Gold Project and identified multiple new targets at Kookynie, backed by a $5 million capital raise. The company is poised for a busy second half of 2025 with assay results and further drilling on the horizon.

Avenira Limited has advanced its Wonarah Phosphate Project with Northern Territory Government approval of its Mine Management Plan and secured $7.57 million through a placement to Hebang, while deferring operational start to optimize costs.

Celsius Resources has launched an updated feasibility study and front-end engineering design for its flagship MCB Copper-Gold Project, backed by a $76.4 million bridge loan from the Philippine sovereign wealth fund. The company also raised A$1.7 million in equity and progressed environmental and social initiatives across its portfolio.

IMEXHS Limited reported steady Q2 FY25 revenue with an 11% rise in annual recurring revenue, supported by a $2.6 million capital raise and operational advances including a major Mexican contract win.

TerraCom reported steady coal sales for the June quarter despite softer thermal coal prices and weather disruptions, opting to withhold dividends while advancing key projects.

Renascor Resources has achieved provisional development approval for its commercial-scale Battery Anode Material manufacturing facility, alongside significant progress in graphite production and exploration activities. The company maintains a robust cash position of A$105 million as it advances its vertically integrated graphite project.

Australian Pacific Coal Limited has entered receivership over its Dartbrook Joint Venture assets following a senior secured debt default, casting doubt on the value of its 80% stake. Despite holding cash reserves, the company assumes no value in the joint venture amid ongoing financial distress.

Tasman Resources progresses exploration at Lake Torrens and Parkinson Dam projects while managing capital through a recent entitlement offer and loan repayments.

Tissue Repair Limited reports steady progress in its Phase 3 clinical trials for TR987® despite patient recruitment hurdles, while TR Pro+® sales surge and new distribution deals pave the way for international growth.

Clarity Pharmaceuticals has bolstered its cash reserves to approximately $288 million following a $203 million institutional placement, while reporting significant clinical progress across multiple copper-based radiopharmaceutical trials targeting prostate cancer and neuroendocrine tumours.

Delorean Corporation has marked significant progress in Q4 FY2025, advancing its renewable gas infrastructure and securing crucial regulatory support that could unlock new revenue streams.

Audio Pixels Holdings reports a delay in its MEMS wafer production due to a key fabrication step requiring revision, while its shares remain suspended on the ASX. The company signals the need for additional funding within six months to sustain its R&D efforts.